3-year results of EYLEAHD® (Aflibercept) injection 8 mg Patients with moist age-related macular degeneration demonstrate continuous durability of increased vision and anatomical improvement.

3-year results of EYLEAHD® (Aflibercept) injection 8 mg Patients with moist age-related macular degeneration demonstrate continuous durability of increased vision and anatomical improvement.